225 related articles for article (PubMed ID: 34330186)
1. What is the gold standard model for Alzheimer's disease drug discovery and development?
Cacabelos R; Carrera I; Martínez-Iglesias O; Cacabelos N; Naidoo V
Expert Opin Drug Discov; 2021 Dec; 16(12):1415-1440. PubMed ID: 34330186
[No Abstract] [Full Text] [Related]
2. The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases.
Hurley MJ; Deacon RMJ; Beyer K; Ioannou E; Ibáñez A; Teeling JL; Cogram P
Pharmacol Ther; 2018 Aug; 188():36-44. PubMed ID: 29514054
[TBL] [Abstract][Full Text] [Related]
3. First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
Cogram P; Garduño BM; Ren B; Xu X
J Alzheimers Dis; 2024; 98(1):333-336. PubMed ID: 38393919
[TBL] [Abstract][Full Text] [Related]
4. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.
Bales KR
Expert Opin Drug Discov; 2012 Apr; 7(4):281-97. PubMed ID: 22458501
[TBL] [Abstract][Full Text] [Related]
5. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of Neuroinflammation Effective in Alzheimer's Disease Models.
Zhou W; Zhong G; Fu S; Xie H; Chi T; Li L; Rao X; Zeng S; Xu D; Wang H; Sheng G; Ji X; Liu X; Ji X; Wu D; Zou L; Tortorella M; Zhang K; Hu W
ACS Chem Neurosci; 2016 Nov; 7(11):1499-1507. PubMed ID: 27504670
[TBL] [Abstract][Full Text] [Related]
6. Rodent models for Alzheimer's disease drug discovery.
Puzzo D; Gulisano W; Palmeri A; Arancio O
Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
[TBL] [Abstract][Full Text] [Related]
7. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
8. Animal models of Alzheimer's disease: therapeutic implications.
Woodruff-Pak DS
J Alzheimers Dis; 2008 Dec; 15(4):507-21. PubMed ID: 19096153
[TBL] [Abstract][Full Text] [Related]
9. Animal models in the drug discovery pipeline for Alzheimer's disease.
Van Dam D; De Deyn PP
Br J Pharmacol; 2011 Oct; 164(4):1285-300. PubMed ID: 21371009
[TBL] [Abstract][Full Text] [Related]
10. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
[TBL] [Abstract][Full Text] [Related]
11. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
12. Non human primate models for Alzheimer's disease-related research and drug discovery.
Van Dam D; De Deyn PP
Expert Opin Drug Discov; 2017 Feb; 12(2):187-200. PubMed ID: 27960560
[TBL] [Abstract][Full Text] [Related]
13. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.
Lublin AL; Link CD
Drug Discov Today Technol; 2013; 10(1):e115-e119. PubMed ID: 24050239
[TBL] [Abstract][Full Text] [Related]
15. Zebrafish as an Experimental and Preclinical Model for Alzheimer's Disease.
Bhattarai P; Turgutalp B; Kizil C
ACS Chem Neurosci; 2022 Oct; 13(20):2939-2941. PubMed ID: 36194560
[TBL] [Abstract][Full Text] [Related]
16. Transgenic C. elegans as a model in Alzheimer's research.
Wu Y; Luo Y
Curr Alzheimer Res; 2005 Jan; 2(1):37-45. PubMed ID: 15977988
[TBL] [Abstract][Full Text] [Related]
17. Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Cacabelos R
Expert Opin Drug Discov; 2018 Jun; 13(6):523-538. PubMed ID: 29607687
[TBL] [Abstract][Full Text] [Related]
18. Recent rodent models for Alzheimer's disease: clinical implications and basic research.
Braidy N; Muñoz P; Palacios AG; Castellano-Gonzalez G; Inestrosa NC; Chung RS; Sachdev P; Guillemin GJ
J Neural Transm (Vienna); 2012 Feb; 119(2):173-95. PubMed ID: 22086139
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's Disease Model System Using Drosophila.
Tsuda L; Lim YM
Adv Exp Med Biol; 2018; 1076():25-40. PubMed ID: 29951813
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer's Disease.
Thawkar BS; Kaur G
Neurotox Res; 2021 Jun; 39(3):949-965. PubMed ID: 33687726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
